The Cannabidiol Market Report is Segmented by Source (Hemp and Marijuana), End Use (Pharmaceuticals, Wellness & Personal Use, and More), Product Form (Oils & Tinctures, Capsules & Softgels, and More), Distribution Channel (Hospital & Specialty Pharmacies, Retail Stores, and More), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, South America). The Market Forecasts are Provided in Terms of Value (USD).

Natural wellness revolution! $9.81B CBD market expanding across pharmaceuticals, beauty care & food. Uncover winning strategies from Aurora Cannabis, Canopy Growth & top innovators

Cannabidiol (CBD) Market Outlook

As per our latest research, the global Cannabidiol (CBD) market size in 2024 reached USD 9.4 billion, reflecting a robust expansion in the wellness and medical sectors. The industry is projected to maintain a strong growth trajectory with a CAGR of 21.2% from 2025 to 2033. By the end of 2033, the CBD market is forecasted to attain a value of USD 62.8 billion. The primary growth factor is the accelerating adoption of CBD-based products across a diverse range of end-user industries, underpinned by increasing consumer awareness and evolving regulatory frameworks worldwide.

The growth of the Cannabidiol (CBD) market is significantly propelled by the increasing legalization and decriminalization of cannabis and hemp-derived products in various regions. As governments across North America, Europe, and parts of Latin America ease regulatory restrictions, manufacturers are able to introduce innovative CBD products into the mainstream market. Consumers are rapidly gravitating towards natural and plant-based therapeutic options, with CBD products gaining traction for their purported benefits in pain management, anxiety relief, and chronic disease mitigation. The proliferation of research on CBDÂ’s efficacy, coupled with endorsements from medical professionals and wellness influencers, further accelerates consumer acceptance, driving the marketÂ’s upward momentum.

Another key driver for the Cannabidiol (CBD) market is the surge in demand from the pharmaceutical and nutraceutical sectors. CBDÂ’s non-psychoactive profile and its potential therapeutic properties have positioned it as a promising ingredient in the formulation of drugs and dietary supplements. Pharmaceutical companies are investing in clinical trials to validate the safety and efficacy of CBD-based medications for conditions such as epilepsy, multiple sclerosis, and sleep disorders. Simultaneously, the nutraceutical industry is leveraging CBD in functional foods and beverages, capitalizing on consumer trends favoring preventive healthcare and holistic wellness. This cross-sectoral integration is fostering a dynamic market landscape and expanding the application scope of CBD.

Technological advancements in extraction and processing methods are also playing a pivotal role in the growth of the Cannabidiol (CBD) market. Innovations such as CO2 extraction and nanoemulsion technology are enabling manufacturers to produce high-purity, bioavailable, and consistent CBD formulations. These advancements not only improve product quality but also enhance scalability and cost-efficiency for producers. Moreover, the expansion of distribution channels, particularly the rise of e-commerce and direct-to-consumer platforms, has made CBD products more accessible to a global audience. This omnichannel approach is breaking down barriers to entry, allowing both established players and new entrants to reach a wider customer base.

Regionally, North America continues to dominate the Cannabidiol (CBD) market, accounting for the largest share in 2024. The United States, in particular, benefits from a progressive regulatory environment, a well-established supply chain, and high consumer awareness. Europe is rapidly emerging as a lucrative market, driven by regulatory harmonization and increasing investments in research and development. The Asia Pacific region is witnessing growing interest, especially in countries like Australia, Japan, and South Korea, where regulatory reforms are underway. Latin America and the Middle East & Africa are gradually opening up, presenting untapped opportunities for market expansion as local governments reconsider their stance on cannabinoid products.

The increasing popularity of CBD is not only reshaping consumer preferences but also influencing the strategic direction of many companies within the wellness and pharmaceutical industries. As more research highlights the potential health benefits of CBD, including its anti-inflammatory and anxiolytic properties, businesses are keen to integrate CBD into their product lines. This trend is evident in the growing number of partnerships between CBD producers and established wellness brands, aiming to capitalize on the burgeoning demand. Additionally, the shift towards natural and holistic health solutions is encouraging more consu

Snapshot img

Cannabidiol (CBD) Market Size 2025-2029

The cannabidiol (CBD) market size is forecast to increase by USD 56.5 billion, at a CAGR of 24.8% between 2024 and 2029.

The CBD market is experiencing significant growth, driven primarily by the ongoing legalization and regulatory changes surrounding cannabidiol. This evolving regulatory landscape presents both opportunities and challenges for market participants. On the one hand, increasing legalization allows for broader market access, fostering growth in various end-use industries such as food and beverages, cosmetics, and pharmaceuticals. On the other hand, the high cost of CBD products poses a significant challenge for consumer adoption and market penetration. The e-commerce industry plays a crucial role in the CBD market's growth, enabling brands to reach a wider audience and offering consumers the convenience of purchasing products online.
However, the high cost of CBD products, largely due to production and extraction expenses, may limit market expansion and create barriers for smaller players. To capitalize on market opportunities and navigate challenges effectively, companies must focus on optimizing production costs, exploring alternative extraction methods, and developing innovative, competitively priced products. By addressing these challenges and leveraging the growing demand for CBD, businesses can position themselves for success in this dynamic and rapidly evolving market.

What will be the Size of the Cannabidiol (CBD) Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.
Request Free Sample

The CBD market continues to evolve at an unprecedented pace, with new developments and trends emerging constantly. One of the most significant areas of growth is product differentiation, as companies strive to distinguish themselves in a crowded marketplace. CBD for inflammation is a popular application, with many brands offering various forms of CBD, including capsules, gummies, and topicals. Cannabis-derived CBD and hemp-derived CBD are two distinct categories, each with its unique advantages and challenges. The legal framework surrounding CBD is also a dynamic factor, with regulations evolving to accommodate the growing industry. Bioavailability is another critical aspect, with brands investing in research to improve the efficacy of their products through advanced formulation and delivery methods.

Consumer education is essential as the market becomes more complex, with various CBD types, such as broad spectrum and full spectrum, and different extraction methods, such as CO2 and ethanol. Brand awareness and loyalty are also crucial, with companies focusing on sustainable practices, transparency, and competitive pricing strategies to attract and retain customers. CBD's applications extend beyond human health, with the pet market showing significant growth. Pricing strategies vary, with some brands adopting a direct-to-consumer model, while others rely on retail channels and wholesale distribution. Regulations continue to shape the industry, with a focus on ensuring safety and quality, particularly in the areas of labeling, clinical trials, and intellectual property.

The CBD market's continuous evolution reflects the ongoing research and innovation in this field. From CBD oil to CBD vape products, CBD for anxiety to CBD for athletes, the potential applications of CBD are vast and ever-expanding. As the industry matures, it is essential to stay informed about the latest trends, regulations, and consumer preferences to remain competitive and succeed in this dynamic market.

How is this Cannabidiol (CBD) Industry segmented?

The cannabidiol (CBD) industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Source

  Marijuana
  Hemp


Distribution Channel

  Offline
  Online


End-user

  Medical
  Personal use
  Wellness


Geography

  North America

    US
    Canada
    Mexico


  Europe

    France
    Germany
    UK


  APAC

    China
    India
    Japan
    South Korea


  Rest of World (ROW)

.

By Source Insights

The marijuana segment is estimated to witness significant growth during the forecast period.

CBD, a non-psychoactive compound derived from the cannabis plant, has gained significant attention in the health and wellness industry due to its potential therapeutic benefits. Different forms of CBD products cater to various consumer preferences, including capsules, oils, topicals, edibles, vape products, and tinctures. The market for CBD continues to grow rapidly, driven by increasing consumer awareness and acceptance, favorable legal frameworks, and expanding product innovation.

The Cannabidiol (CBD) Oil Market Report is Segmented by Source Type (Hemp-Derived, Marijuana-Derived), Product Form (Capsules & Softgels and More), Sales Type (B2B, B2C [Offline Retail Pharmacies and More]), End-Use Sector (Cosmetics & Beauty and More), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America). The Market Forecasts are Provided in Terms of Value (USD).

Discover the flourishing Europe CBD market projected to grow at a 24.57% CAGR by 2028. Legalization and increasing acceptance drive the market's expansion.

Global Cannabidiol Market size was valued at around USD 22.7 billion in 2023 and is projected to grow at a CAGR of around 19.21% during the forecast period 2024-30. increasing popularity of functional CBD products is one of the key trends shaping the growth of cbd market.

The North America Hemp-derived Cannabidiol Market size was valued at USD 2.9 billion in 2023 and is projected to reach USD 16.06 billion by 2032, exhibiting a CAGR of 27.7 % during the forecasts period. The North American hemp-derived cannabidiol (CBD) market is mainly about CBD oil and other products obtained from industrial hemp which has very low levels of THC that offers medicinal use and its benefits without causing the feeling of ‘high.’ Media uses are analgesic, anxiolytic/antianxiety, anti-inflammatory, and dermatological/wound healing. The market has continued to expand because of changing consumption knowledge, legalization patterns, and acceptance of CBD in the global wellness and healthcare Industries. Trends are that CBD comes in various types of merchandise with oils, edibles, topicals, capsules, and so on and organically sourced CBD. Thus, regulatory updates and scientific research make the market more solid and push the market growth, improving the credibility and safety of products.

Cannabidiol (CBD): CBD is the most common type of cannabinoid found in the cannabis plant. It is non-psychoactive and has various therapeutic benefits.Form: CBD is available in both solid and liquid forms. Solid forms include capsules, tablets, and edibles, while liquid forms include tinctures, oils, and vape liquids.Route of Administration: CBD can be administered through various routes, including tincture, capsules, inhalation (smoke or vapor), and aerosol spray.Product: CBD products can be classified into food grade and therapeutic grade, depending on their intended use.Application: CBD has a wide range of applications in healthcare, including neurodegenerative disorders, fibromyalgia, diabetes, and various other conditions. Recent developments include: June 2021: For about USD 60 million, The Valens Company finalized the purchase of Green Roads. The acquisition provides The Valens Company with a well-established Green Road network that allows it access to the U.S. CBD industry., October 2020: Researchers and faculty at the Medical College of Georgia and the Dental College of Georgia have shown how cannabidiol (CBD) can cause significantly less lung damage and inflammation. They have also demonstrated how CBD can raise oxygen levels for disorders connected to adult respiratory problems.. Key drivers for this market are: Growing Research And Development Activities And Financial Support By Various Private And. Potential restraints include: Adverse Effects Associated With Cannabis 25, Stringent Government Policies 25. Notable trends are: Increasing the use of cannabidiol (CBD) for medicinal purposes will boost the market growth.

The global Cannabidiol (CBD) ingredient market is experiencing robust growth, driven by increasing consumer awareness of CBD's potential health benefits and its expanding applications across various industries. While precise market figures for 2025 aren't provided, considering a conservative estimate based on industry reports indicating a market size in the billions and a typical CAGR of 20-25% for emerging markets, a reasonable projection for the 2025 market size would be $5 billion USD. Projecting a continued, albeit slightly moderating, growth rate of 18% CAGR for the forecast period (2025-2033), the market is poised to reach approximately $20 billion by 2033. This growth is fueled by several key factors including the legalization and decriminalization of cannabis in various regions, increasing research into CBD's therapeutic potential, and the growing popularity of CBD-infused products in food & beverages, personal care, nutraceuticals, and pharmaceuticals. The market segmentation shows significant traction across all application areas, with Food & Beverages and Personal Care & Cosmetics currently leading the charge, followed by a rapidly expanding Nutraceutical segment. The natural marijuana-based CBD segment holds the largest market share due to consumer preference for natural products, although synthetic CBD offers cost advantages and potential for standardization that will drive its own growth in the coming years. The competitive landscape is marked by a mix of established players and emerging companies, reflecting the dynamic nature of the CBD market. Key players are focusing on innovation, product diversification, and strategic partnerships to capture market share. Challenges remain, particularly around regulatory uncertainty in certain regions and concerns about product quality and standardization. However, the ongoing research and development efforts, alongside increasing regulatory clarity in key markets, are expected to address these concerns, further propelling market expansion. Continued innovation in extraction methods and formulation technologies will also contribute to the overall growth trajectory. The regional distribution demonstrates a strong presence in North America, with the United States leading the market, followed by Europe and Asia Pacific regions showing promising growth potential. The expansion into emerging markets will play a crucial role in future market growth, particularly in regions with increasing acceptance of CBD products.

Cannabidiol (CBD) Market is estimated to be US$ 17.5 billion by 2034 with a CAGR of 10.3% during the forecast period

Vendor Performance

The global market for CBD products for relaxation is experiencing significant growth, driven by increasing awareness of CBD's potential benefits for stress reduction, anxiety relief, and improved sleep quality. The market, valued at approximately $2.5 billion in 2025, is projected to exhibit a robust Compound Annual Growth Rate (CAGR) of 15% from 2025 to 2033. This expansion is fueled by several key factors, including the increasing legalization and acceptance of CBD in various regions, rising consumer demand for natural and alternative therapies, and the expanding availability of CBD products through diverse retail channels, both online and offline. The popularity of CBD gummies and oils specifically designed for relaxation contributes significantly to this market segment's growth. Furthermore, the personal care segment dominates the application-based breakdown, reflecting the individual-focused nature of stress management and relaxation practices. However, the family segment is also showing promising growth, indicating a broader acceptance of CBD's potential for holistic wellbeing. Competition within the market is intense, with numerous established brands and emerging players vying for market share. Key players, including CBDistillery, Purekana, and others listed in the provided data, are focusing on product innovation, expanding distribution networks, and enhancing brand awareness to maintain their competitive edge. Despite the promising outlook, market growth faces challenges such as regulatory hurdles in some regions, concerns regarding product quality and standardization, and potential negative perceptions surrounding CBD's legal status and efficacy. The forecast period will likely see continued innovation in product formulations, delivery methods, and marketing strategies, shaping the landscape of the CBD relaxation market significantly. The expanding research base on CBD's therapeutic potential, coupled with increasing consumer awareness, positions the market for continued, substantial growth in the coming years.

The global Cannabidiol (CBD) Market size is expected to reach USD 46.47 Billion in 2032 registering a CAGR of 28.3% Discover the latest trends and analysis on the Cannabidiol (CBD) Market. Our report provides a comprehensive overview of the industry, including key players, market share, growth oppor...

The CBD oil market was valued at $5,230.9 million in 2024 and will reach $23,483.2 million by 2032, advancing at a CAGR of 20.8% during 2025-2032.

Market Analysis of Cannabidiol (CBD) The global CBD market is poised to grow exponentially, with a market size of $720.5 million in 2025 and a CAGR of 28.3% from 2025 to 2033. Drivers of this growth include increasing legalization of cannabis, rising consumer awareness of CBD's health benefits, and growing demand in the pharmaceutical, food, and cosmetics industries. Trends in the market include the development of new CBD products, the expansion of online sales channels, and the focus on sustainability. Key segments of the CBD market include types (hemp-derived and marijuana-derived) and applications (pharmaceuticals, food, cosmetics, and others). North America dominates the market, driven by strong demand in the United States. Other regions with significant growth potential include Europe and Asia Pacific. Major companies in the industry include Kazmira, CW Hemp/CW Botanicals, and Freedom Leaf. The study period for this analysis spans 2019-2033, with a base year of 2025 and a forecast period of 2025-2033.

The CBD Oil Market is estimated to be valued at USD 0.8 billion in 2025 and is projected to reach USD 12.5 billion by 2035, registering a compound annual growth rate (CAGR) of 31.0% over the forecast period.

The global cannabidiol (CBD) extract market is experiencing robust growth, driven by increasing consumer awareness of CBD's potential health benefits and its expanding applications in various industries. The market, while still relatively young, shows significant promise, with a projected Compound Annual Growth Rate (CAGR) allowing for substantial market expansion over the next decade. Factors such as the legalization of CBD in several regions, coupled with increasing research validating its therapeutic properties for conditions like anxiety, pain, and sleep disorders, are key drivers. Furthermore, the versatility of CBD extracts, enabling their use in diverse products like skincare, edibles, and supplements, fuels market expansion. While regulatory uncertainties and varying legal frameworks across different geographies pose challenges, the overall positive trajectory suggests a promising future for the CBD extract market. Leading companies like Aphria, Aurora Cannabis, Canopy Growth, Maricann, Organigram, Cronos Group, Tikun Olam, and Tilray are actively shaping this market landscape through innovation and expansion strategies. The market segmentation reveals various product forms and application areas, each exhibiting unique growth patterns. The regional distribution of the market shows significant traction in North America and Europe, reflecting the higher acceptance and legalization of CBD products in these regions. Future growth will likely be influenced by the continuing evolution of regulatory landscapes, advancements in CBD extraction technologies, and increasing consumer demand fueled by positive clinical research and brand awareness campaigns. The forecast period of 2025-2033 reveals a substantial market expansion. Assuming a conservative CAGR of 15% (a reasonable estimate based on current market trends), and a 2025 market size of $5 billion (a plausible figure considering current market valuations and growth projections), the market value would reach approximately $16 billion by 2033. This substantial increase highlights the considerable investment opportunities and potential for market disruption within the CBD extract sector. However, consistent monitoring of regulatory changes, emerging competitor dynamics, and evolving consumer preferences will be crucial for sustained success within this dynamic market.

CBD Oil Market size was valued at 24.99 USD Billion in 2024 and is projected to reach 281.52 USD Billion by 2031, growing at a CAGR of 39% from 2024 to 2031.Global CBD Oil Market DriversThe market drivers for the CBD Oil Market can be influenced by various factors. These may include:Increasing Acceptance and Awareness Among Consumers: Demand is being driven by consumers' growing awareness of the potential health advantages of CBD oil, including its usage in treating a variety of ailments like chronic pain, anxiety, insomnia, and inflammation. The potential medicinal benefits of CBD oil are becoming more widely recognized as more individuals turn to natural and alternative therapies.Legalization and Regulatory Reforms: The legalization of cannabis and CBD products derived from hemp in a number of jurisdictions, along with beneficial regulatory changes, has created new market opportunities. The market for CBD oil has expanded thanks to changes in legislation, such as the U.S. Farm Bill that was passed in 2018 and authorized hemp farming while removing CBD derived from hemp from the Controlled Substances Act.Growing Product Accessibility and Availability: CBD oil products are now widely available as tinctures, capsules, topicals, and edibles, among other forms. Growing consumer access to CBD oil has been facilitated by expanded distribution channels, such as dispensaries, pharmacies, specialty shops, and internet sellers.Increasing Usage Application: CBD oil is finding more and more uses in skincare, cosmetics, pet care, food, and drink, among other areas outside wellness and health. The market reach and attractiveness of CBD oil have grown as a result of the product line's diversification, as well as the introduction of cutting-edge formulations and distribution techniques.

The Cannabidiol Oil (CBD) Supplements market is experiencing robust growth, with a market size of $567.2 million in 2025 and a projected Compound Annual Growth Rate (CAGR) of 3.3% from 2025 to 2033. This expansion is driven by increasing consumer awareness of CBD's potential health benefits, including its purported anti-inflammatory and anxiolytic properties. The rising prevalence of chronic conditions like anxiety and insomnia, coupled with a growing preference for natural and holistic wellness solutions, further fuels market demand. Significant innovation in product formats, including tinctures, capsules, topicals, and edibles, caters to diverse consumer preferences and contributes to market growth. Key players like Kazmira, Freedom Leaf, and Canopy Growth Corporation are actively shaping the market landscape through strategic expansions, product diversification, and targeted marketing campaigns. The competitive landscape is characterized by a mix of established brands and emerging players, fostering innovation and accessibility. However, regulatory uncertainties surrounding CBD remain a significant challenge. Varying legal frameworks across different regions create obstacles for market expansion and consistent product standardization. Concerns about product quality and purity, along with potential side effects, also influence consumer perception and adoption. Despite these restraints, the long-term outlook for the CBD supplements market remains positive. Continued research into CBD's therapeutic potential, coupled with increasing regulatory clarity and consumer education, are expected to drive sustained growth throughout the forecast period. The market's segmentation, encompassing various product forms and distribution channels, allows for targeted market penetration and expansion.